Mayo Clinic Department of Molecular Pharmacology and Experimental Therapeutics
United States of America (USA)
1 November 2019 - 31 October 2020
Principal institution: Mayo Clinic
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Mayo Clinic Department of Molecular Pharmacology and Experimental Therapeutics published between 1 November 2019 - 31 October 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 16 | 3.10 |
Outputs by subject (Share)
| Subject | Count | Share | |
|---|---|---|---|
| Life Sciences | 16 | 3.10 | |
| Chemistry | 3 | 0.79 | |
| Physical Sciences | 1 | 0.20 | |
Top articles by Altmetric score in current window
Intrinsic Endocardial Defects Contribute to Hypoplastic Left Heart Syndrome.
Cell Stem Cell
2020-08-10
Sex and APOE ε4 genotype modify the Alzheimer’s disease serum metabolome
Nature Communications
2020-03-02
Structure and dynamics of the active Gs-coupled human secretin receptor
Nature Communications
2020-08-18
Parallel bimodal single-cell sequencing of transcriptome and chromatin accessibility
Genome Research
2020-07-22
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
